While resistance is a natural evolutionary process, the review shows that human activity has dramatically intensified its ...

The Infection Control Academy of India has urged Finance Minister Nirmala Sitharaman to adopt a progressive GST on antibiotics. Access drugs would remain cheap, while Watch and Reserve antibiotics ...

Basilea Pharmaceutica has partnered with INCATE, the European incubator for antibacterial therapies, to support the advancement of early-stage anti-infective innovations. As an industry partner, ...

The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced ...

Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, announced plans to unveil the company’s lead candidate at the upcoming Interdisciplinary ...

Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, announced plans ...

Bacterial Conjunctivitis Drugs Market is expected to reach US$ 4.9 Billion by 2036, Driven by Increasing Prevalence of Eye ...

A new superbug strain of drug-resistant typhoid fever has emerged in South Asia, raising global health concerns. Researchers ...

New strains of Typhoid that can resist the strongest available antibiotics have emerged in South Asia, raising concerns over the potential spread of drug-resistant infections.

Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed ...

Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infectives, today announced an agreement with Basilea Pharmaceutica Ltd, Allschwil ...

Antimicrobial stewardship (AMS) refers to coordinated strategies for the targeted, evidence-based, and safe use of ...